Publication: Association of the Long Non-coding RNA Steroid Receptor RNA Activator (SRA) with TrxG and PRC2 Complexes
Issued Date
2015-01-01
Resource Type
ISSN
15537404
15537390
15537390
Other identifier(s)
2-s2.0-84946606813
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
PLoS Genetics. Vol.11, No.10 (2015)
Suggested Citation
Patompon Wongtrakoongate, Gregory Riddick, Suthat Fucharoen, Gary Felsenfeld Association of the Long Non-coding RNA Steroid Receptor RNA Activator (SRA) with TrxG and PRC2 Complexes. PLoS Genetics. Vol.11, No.10 (2015). doi:10.1371/journal.pgen.1005615 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/35274
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Association of the Long Non-coding RNA Steroid Receptor RNA Activator (SRA) with TrxG and PRC2 Complexes
Other Contributor(s)
Abstract
Long non-coding RNAs (lncRNAs) have been recognized as key players in transcriptional regulation. We show that the lncRNA steroid receptor RNA activator (SRA) participates in regulation through complex formation with trithorax group (TrxG) and polycomb repressive complex 2 (PRC2) complexes. Binding of the SRA-associated RNA helicase p68 preferentially stabilizes complex formation between SRA and a TrxG complex but not PRC2. In human pluripotent stem cells NTERA2, SRA binding sites that are also occupied by p68 are significantly enriched for H3K4 trimethylation. Consistent with its ability to interact with TrxG and PRC2 complexes, some SRA binding sites in human pluripotent stem cells overlap with bivalent domains. CTCF sites associated with SRA appear also to be enriched for bivalent modifications. We identify NANOG as a transcription factor directly interacting with SRA and co-localizing with it genome-wide in NTERA2. Further, we show that SRA is important for maintaining the stem cell state and for reprogramming of human fibroblasts to achieve the pluripotent state. Our results suggest a mechanism whereby the lncRNA SRA interacts with either TrxG or PRC2. These complexes may then be recruited by various DNA binding factors to deliver either activating or silencing signals, or both, to establish bivalent domains.